Isobutyl 2-isobutoxyquinoline-1(2H)-carboxylate | CAS:38428-14-7

We serve Isobutyl 2-isobutoxyquinoline-1(2H)-carboxylate CAS:38428-14-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Isobutyl 2-isobutoxyquinoline-1(2H)-carboxylate

Chemical Name:Isobutyl 2-isobutoxyquinoline-1(2H)-carboxylate
CAS.NO:38428-14-7
Synonyms:1-Isobutoxycarbonyl-2-isobutoxy-1,2-dihydroquinoline;IIDQ
Molecular Formula:C18H25NO3
Molecular Weight:303.39600
 
Physical and Chemical Properties:
Density:1.022;
Melting point:oC;
Boiling point:140-142oC;
Flash point:230oF;
 
HS Code: 2933499090
 
Specification:
Appearance:Colorless clear liquid
Purity(HPLC):≥95.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent



Contact us for information like Isobutyl 2-isobutoxyquinoline-1(2H)-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,IIDQ physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,IIDQ Use and application,Isobutyl 2-isobutoxyquinoline-1(2H)-carboxylate technical grade,usp/ep/jp grade.


Related News: Chinese officials on Sunday reported a surge in new cases.2-Methyltetrahydrofuran-3-thiol manufacturer The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.3-Hydroxy-2-nitropyridine supplier The patient, who arrived from Wuhan, is “stable and under medical care,” the ministry said in a statement, adding there is “no cause for concern” for the public.3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carbonyl chloride vendor In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.